10 results on '"Hu, Ling"'
Search Results
2. The Single-Nucleotide Polymorphism of miR-27a rs895819 and the Expression of miR-27a in Helicobacter pylori-Related Diseases and the Correlation with the Traditional Chinese Medicine Syndrome.
- Author
-
Zhang, Ling, Huang, Meng-Xin, Li, Dan-Yan, Zhang, Yun-Zhan, Lan, Shao-Yang, Luo, Qi, Dai, Yun-Kai, Wu, Yun-Bo, Ye, Jin-Tong, Chen, Wei-Jing, Li, Ru-Liu, and Hu, Ling
- Subjects
REVERSE transcriptase polymerase chain reaction ,STOMACH tumors ,HELICOBACTER pylori ,SINGLE nucleotide polymorphisms ,ONCOGENES ,ALLELES ,GENE expression ,GENOTYPES ,POLYMERASE chain reaction ,HELICOBACTER diseases ,CHINESE medicine ,METHYLENE blue ,GASTRIC mucosa - Abstract
Aims. The study aims to explore the effects of the single-nucleotide polymorphism of miR-27a and its expression in Helicobacter pylori (H. pylori)-related diseases and the relationship between gastric pathology and traditional Chinese medicine (TCM). Methods. Subjects were classified into six histopathological groups and five TCM syndrome groups. All specimens underwent H. pylori detection through rapid urease test and methylene blue staining. Histopathological characteristics were observed by hematoxylin-eosin. The expression of miR-27a and its genotype were, respectively, detected by Quantitative Real-Time PCR and direct sequencing. Results. H. pylori promoted the malignant evolution of gastric mucosa and were involved in the formation of TCM syndrome. In H. pylori-positive patients, the frequency of miR-27a CT genotype at the rs895819 locus and its expression in the gastric cancer group were higher than those in other pathological groups. TCM syndrome had a close relationship with histopathological changes, and patients with spleen-qi deficiency syndrome had a higher risk of gastric cancer than other syndromes, regardless of H. pylori infection. Conclusion. The C allele at miR-27a rs895819 locus may be an oncogene in gastric cancer. High levels of miR-27a could play an important role in gastric malignant evolution, especially cancerization. There is a certain connection between TCM syndrome and pathological changes of the gastric mucosa to some extent, where patients with SQD syndrome had a higher risk of GC. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
3. Pharmacological treatments of Chinese herbal medicine for irritable bowel syndrome in adults: A network meta-analysis of randomized controlled trials.
- Author
-
Wu, Yun-bo, Dai, Yun-kai, Zhang, Ling, Pan, Huai-geng, Chen, Wei-jing, Li, Ru-liu, and Hu, Ling
- Subjects
IRRITABLE colon ,ADULTS ,HERBAL medicine ,RANDOMIZED controlled trials ,CHINESE medicine - Abstract
Introduction: Plenty of clinical studies have suggested the value of Chinese herbal medicine (CHM) for patients with irritable bowel syndrome (IBS), but their efficacy and safety have not been systematically concluded yet. This article aimed to compare and rank the therapeutic effect and safety of CHM with routine pharmacotherapies and placebo in the treatment of IBS. Methods: Randomized controlled trials regarding CHM to treat IBS were searched in six databases from inception to Jan 31, 2020. A network meta-analysis was conducted to analyze the data of included publications. The quality assessment was assessed by Cochrane Handbook and GRADEpro software. The risk ratio was calculated for dichotomous outcomes while the standardized mean difference was used for continuous variables with 95% credible intervals. A Funnel plot was performed to evaluate publication bias. The surface under the cumulative ranking curve was conducted to rank the included interventions. Data were analyzed with STATA 15.0 and Review Manager 5.3. Result: 3194 records were searched, and 28 eligible trials involving 3323 patients ere identified. Compared with conventional therapies and placebo, Jianpi-Chushi therapy showed significant improvement in adequate relief and IBS symptom severity scale; Shugan-Jianpi therapy showed the best efficacy in relieving the abdominal pain and abdominal distension; Wenshen-Jianpi therapy had a better effect on avoiding adverse effects and improving stool character. Conclusion: This study confirmed that CHM could be beneficial for patients with IBS in relieving their clinical symptoms and should be recommended as alternative therapies. The quality of evidence in this study based on the GRADE system was "low". [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
4. Associations of Interleukin-1β with H. pylori-Induced Gastric Atrophy and Syndrome of Dampness-Heat in the Spleen and Stomach in Subjects with H. pylori-Related Gastric Diseases.
- Author
-
Zhang, Yunzhan, Chen, Xu, Gong, Lin, Li, Danyan, Dai, Yun-kai, Lan, Shaoyang, Luo, Qi, Chen, Bin, Chen, Weijing, Li, Ruliu, and Hu, Ling
- Subjects
GENE expression ,GENETIC polymorphisms ,HELICOBACTER diseases ,INTERLEUKIN-1 ,CHINESE medicine ,MESSENGER RNA ,SPLEEN ,GASTRIC diseases ,ATROPHY ,DISEASE complications ,DISEASE risk factors - Abstract
H. pylori-related gastric diseases (HPGD) are a series of gastric mucosal benign and malignant lesions associated with H. pylori infection. Exploring the pathogenesis of HPGD will be of great significance to prevent and treat gastric malignancy. Traditional Chinese medicine (TCM) syndrome is the essence of TCM, reflecting the state of whole body. Potential similarities of TCM syndrome may provide a new perspective in understanding development and treatment of diseases. To seek an early warning signal for gastric malignant pathology and similarities of TCM syndrome from the viewpoint of molecular biology, we examined the relationships among H. pylori, gastric pathology, and TCM syndrome and effects of Interleukin-1β (IL-1β) gene polymorphisms and expression on gastric pathology and TCM syndrome in HPGD. The results indicated that detection of H. pylori with differentiation of TCM syndrome may have a predictive function to gastric pathology. H. pylori may lead to gastric atrophy via enhancing IL-1β mRNA expression, and IL-1β mRNA overexpression in gastric mucosa may be one of the generality characteristics for H. pylori-negative subjects with syndrome of dampness-heat in the spleen and stomach. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
5. Geographic authentication of the traditional Chinese medicine Atractylodes macrocephala Koidz. (Baizhu) using stable isotope and multielement analyses.
- Author
-
Hu, Ling, Chen, Xianfeng, Yang, Jian, and Guo, Lanping
- Subjects
- *
STABLE isotope analysis , *CHINESE medicine , *INDUCTIVELY coupled plasma mass spectrometry , *MASS spectrometry , *CHEMOMETRICS , *TRACE element analysis - Abstract
Rationale: Atractylodes macrocephala Koidz (Baizhu) is a valuable traditional Chinese medicine, and medicines of that type originating from Zhejiang province are the most famous and much more expensive than those from other regions. Driven by the great difference in prices, fraudulent labeling often occurs. In order to protect the interests of consumers, producers and honest traders, reliable techniques for the geographic authentication of Baizhu are needed urgently. Methods: The stable isotope ratios of five light elements (C, N, H, O and S) in Baizhu samples originating from four provinces of China were determined with an elemental analyzer coupled to isotope ratio mass spectrometry, and the concentrations of 45 elements in these samples were measured using inductively coupled plasma mass spectrometry. Chemometric approaches including principal component analysis (PCA) and orthodox partial least squares discriminant analysis (OPLS‐DA) were applied to the obtained data. Results: The PCA results showed that the techniques enabled clear classification of the Baizhu samples into three clusters: A (Zhejiang province), B (Shaanxi province) and C (Hebei and Ahui provinces). Furthermore, OPLS‐DA using 27 key variables provided 100% correct discrimination between samples originating from Zhejiang province and those from the other three provinces. Conclusions: Stable isotope ratio and multielement analyses in combination with chemometric approaches showed great potential for the geographic authentication of Baizhu, providing a promising method for the control of fraudulent labeling that frequently occurs with traditional herbal medicines in China. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
6. Effects of Yangzheng Sanjie Decoction-containing serum mediated by microRNA-7 on cell proliferation and apoptosis in gastric cancer.
- Author
-
ChEN, Wanqun, Yu, Yaya, Yang, Naikun, Zhu, Jingli, Li, Ke, Li, Ruocun, Su, WENqiao, Luo, Lina, Hu, Ling, ChEN, GENgxin, and DENg, Haixia
- Subjects
STOMACH cancer treatment ,CHINESE medicine ,STOMACH cancer ,CANCER-related mortality ,CANCER cell proliferation ,GENETICS - Abstract
Gastric cancer (GC) is one of the most common types of cancer and a leading cause of cancer‑associated mortality. MicroRNAs (miRNAs/miRs) are demonstrated to function as oncomiRs or tumor‑suppressor‑miRs in GC. miR‑7 has been identified to be a tumor suppressor of GC by targeting epidermal growth factor receptor (EGFR). In our previous study, Yangzheng Sanjie Decoction (YZSJD), a traditional Chinese formula, was identified to be effective in alleviating the symptoms and even postponing turnover of precancerous lesions. To elucidate the mechanism of YZSJD, the present study evaluated the effects of YZSJD of the GC MKN‑45 cell line and investigated the underlying molecular mechanisms using YZSJD‑containing serum (YCS). The expression of miR‑7 in GC, normal and adjacent tissue samples was examined. The results demonstrated that YCS inhibited proliferation by inducing cell cycle arrest at the S phase, and significantly induced apoptosis compared with the control group. miR‑7 was significantly downregulated in GC tissues compared with the matched ones. Using reverse transcription‑quantitative polymerase chain reaction and western blot analysis, the expression of miR‑7 was inversely associated with EGFR. This indicates that YCS inhibits proliferation and induces apoptosis of GC cells mediated by miR‑7 targeting EGFR, which may be one of the mechanisms whereby YZSJD exerts its effects on GC. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
7. Systematic review and meta-analysis of traditional Chinese medicine in the treatment of constipation-predominant irritable bowel syndrome.
- Author
-
Li, Dan-yan, Dai, Yun-kai, Zhang, Yun-zhan, Huang, Meng-xin, Li, Ru-liu, Ou-yang, Jia, Chen, Wei-jing, and Hu, Ling
- Subjects
CHINESE medicine ,IRRITABLE colon treatment ,CONSTIPATION ,THERAPEUTICS ,RANDOMIZED controlled trials ,SYSTEMATIC reviews ,META-analysis - Abstract
Aim: This meta-analysis analyzed the efficacy and safety of traditional Chinese medicine (TCM) for the treatment of irritable bowel syndrome with constipation (IBS-C). Methods: We searched seven electronic databases for randomized controlled trials investigating the efficacy of TCM in the treatment of IBS-C. The search period was from inception to June 1, 2017. Eligible RCTs compared TCM with cisapride and mosapride. Article quality was evaluated with the Cochrane Risk Bias Tool in the Cochrane Handbook by two independent reviewers. Begg’s test was performed to evaluate publication bias. Review Manager 5.3 and Stata 12.0 were used for analyses. Results: Eleven eligible studies comprising a total of 906 participants were identified. In the primary outcome, TCM showed significant improvement in overall clinical efficacy compared with cisapride and mosapride (odds ratio [OR] = 4.00; 95% confidence interval [CI]: 2.74,5.84; P < 0.00001). In terms of secondary outcomes, TCM significantly alleviated abdominal pain (OR = 5.69; 95% CI: 2.35, 13.78; P = 0.0001), defecation frequency (OR = 4.38; 95% CI: 1.93, 9.93. P = 0.0004), and stool form (OR = 4.96; 95% CI: 2.11, 11.65; P = 0.0002) in the treatment group as compared to the control group. A lower recurrence rate was associated with TCM as compared to cisapride and mosapride (OR = 0.15; 95% CI: 0.08, 0.27; P < 0.00001). No adverse effects were observed during TCM treatment. Conclusions: TCM showed greater improvement in terms of clinical efficacy in the treatment of IBS-C than cisapride and mosapride, although it was not possible to draw a definitive conclusion due to the small sample size, high risk, and low quality of the studies. Large multi-center and long-term high-quality randomized control trials are needed. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
8. Are the Therapeutic Effects of Huangqi ( ) on Diabetic Nephropathy Correlated with Its Regulation of Macrophage iNOS Activity?
- Author
-
Liao, Hui, Hu, Ling, Cheng, Xingnuo, Wang, Xiaocheng, Li, Jiarui, Banbury, Linda, and Li, Rongshan
- Subjects
- *
DIABETIC nephropathies , *ASTRAGALUS membranaceus , *NITRIC-oxide synthases , *LIPOPOLYSACCHARIDES , *MACROPHAGES , *NITRIC oxide , *THERAPEUTICS , *DRUG therapy , *ASTRAGALUS (Plants) , *BIOCHEMISTRY , *CLINICAL trials , *PHENOMENOLOGY , *CHINESE medicine , *META-analysis , *OXIDOREDUCTASES , *KIDNEY failure , *SYSTEMATIC reviews , *DISEASE progression , *PHYSIOLOGY - Abstract
Objective: To investigate the correlation between the clinical effects of Huangqi (Astragalus membranaceus) on different stages of diabetic nephropathy (DN) and the pharmacological effect of Huangqi on the activity of inducible nitric oxide synthase (iNOS) in macrophages in different states.Methods: The PubMed, China National Knowledge Infrastructure, and Wanfang databases were searched. Clinical data was sourced from papers on treatment of different stages of DN with Huangqi, and pharmacological data was from papers on the effects of Huangqi on the iNOS activity of macrophages in a resting or an activated state.Results: Meta-analysis of Huangqi injections on stages III and III-IV DN and randomized controlled trials on other stages showed that Huangqi had therapeutic effects on different stages of DN and on macrophages in different states: inducing normal macrophages in a resting state to generate nitric oxide (NO), tumor necrosis factor-α, and so forth upon iNOS activation; inhibiting NO generation by normal lipopolysaccharide- (LPS-) activated macrophages; and enhancing NO generation by LPS-induced macrophages from patients with renal failure.Conclusions: Huangqi can regulate iNOS activity of macrophages in different states in vitro. These biphasic or antagonistic effects may explain why Huangqi can be used to treat different stages of DN. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
9. Efficacy and Safety of Modified Banxia Xiexin Decoction (Pinellia Decoction for Draining the Heart) for Gastroesophageal Reflux Disease in Adults: A Systematic Review and Meta-Analysis.
- Author
-
Dai, Yunkai, Zhang, Yunzhan, Li, Danyan, Ye, Jintong, Chen, Weijing, and Hu, Ling
- Subjects
GASTROESOPHAGEAL reflux treatment ,HEARTBURN ,HERBAL medicine ,CHINESE medicine ,META-analysis ,SYSTEMATIC reviews ,PLANT extracts ,TREATMENT effectiveness ,MEDICAL drainage - Abstract
Modified Banxia Xiexin decoction (MBXD) is a classical Chinese herbal formula in treating gastroesophageal reflux disease (GERD) for long time, but the efficacy of it is still controversial. This study is to evaluate the efficacy and safety of MBXD for the treatment of GERD in adults. The search strategy was carried out for publications in seven electronic databases. RevMan software version 5.3 and the Cochrane Collaboration’s risk of bias tool were performed for this review. Twelve RCTs were included for the analysis. The results of overall clinical efficacy and efficacy under gastroscope demonstrated that MBXD was superior to conventional western medicine. Meanwhile, the results of subgroup analysis showed clinical heterogeneity between the two groups. However, there was no statistically significant difference in acid regurgitation between the two groups. But in the improvement of heartburn and sternalgia, the results showed statistically significant differences for the comparison between two groups. In addition, the adverse reactions of the experiment groups were not different from those of the control groups. This systematic review indicates that MBXD may have potential effects on the treatment of patients with GERD. But because the evidence of methodological quality and sample sizes is weak, further standardized researches are required. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
10. Protection against COVID-19 injury by qingfei paidu decoction via anti-viral, anti-inflammatory activity and metabolic programming.
- Author
-
Chen, Jian, Wang, Yong-kui, Gao, Yuan, Hu, Ling-San, Yang, Jiang-wei, Wang, Jian-ru, Sun, Wen-jie, Liang, Zhi-qiang, Cao, Ye-min, and Cao, Yong-bing
- Subjects
- *
COVID-19 , *OBSTRUCTIVE lung diseases , *CHINESE medicine , *SARS-CoV-2 , *HERBAL medicine - Abstract
• A novel FUNP analysis on QFPD function. • QFPD act on COVID-19 via anti-viral, anti-inflammatory and metabolic programming. • 9 QFPD ingredients presented good molecular docking score for 2019-nCov. • SGMH, MXSG and Others are the top 3 efficient formula for COVID-19. Qingfei Paidu decoction (QFPD), a multi-component herbal formula, has been widely used to treat COVID-19 in China. However, its active compounds and mechanisms of action are still unknown. Firstly, we divided QFPD into five functional units (FUs) according to the compatibility theory of traditional Chinese medicine. The corresponding common targets of the five FUs were all significantly enriched in Go Ontology (oxidoreductase activity, lipid metabolic process, homeostatic process, etc.), KEGG pathways (steroid biosynthesis, PPAR signaling pathway, adipocytokine signaling pathway, etc.), TTD diseases (chronic inflammatory diseases, asthma, chronic obstructive pulmonary Disease, etc.), miRNA (MIR183), kinase (CDK7) and TF (LXR). QFPD contained 257 specific targets in addition to HCoV, pneumonia and ACE2 co-expression proteins. Then, network topology analysis of the five components-target-pathway-disease networks yielded 67 active ingredients. In addition, ADMET estimations showed that 20 compounds passed the stringent lead-like criteria and in silico drug-likeness test with high gastrointestinal absorption and the median lethal dose (LD50 > 1600 mg/kg). Moreover, 4 specific ingredients (M3, S1, X2 and O2) and 5 common ingredients (MS1, MX16, SX1, WO1 and XO1) of QFPD presented good molecular docking score for 2019-nCov structure and non-structure proteins. Finally, drug perturbation of COVID-19 network robustness showed that all five FUs may protect COVID-19 independently, and target 8 specifically expressed drug-attacked nodes which were related to the bacterial and viral responses, immune system, signaling transduction, etc. In conclusion, our new FUNP analysis showed that QFPD had a protection effect on COVID-19 by regulating a complex molecular network with safety and efficacy. Part of the mechanism was associated with the regulation of anti-viral, anti-inflammatory activity and metabolic programming. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.